Advertisement
You have a preview view of this article while we are checking your access. When we have confirmed access, the full article content will load.
Prostate Cancer Screening Now Broadly Recommended, Reversing Past Guidance
Universal screening for the disease has long been a subject of controversy.
Listen
· 6:52 min
Nov. 12, 2026, 7:00 a.m. ET
The American Cancer Society on Thursday issued new guidelines recommending that all men ages 50 to 69 undergo prostate cancer screening using a blood test every two years.
Black men and those with a strong family history of prostate cancer should start annual screening at 45, the guidelines said.
Universal screening for prostate cancer, which accounts for about 2.5 percent of all deaths among U.S. men, has long been a subject of controversy. The evidence of the benefits of regular testing of blood levels of prostate specific antigen, or P.S.A., is somewhat limited. And there are well-documented harms associated with diagnosing and treating all prostate cancers, which are typically slow growing and may not ever cause issues in men who have them.
The new guidelines diverge from earlier recommendations that patients and physicians decide together about screening, based on careful consideration of the risks and benefits and patients’ values.
“This is truly a reversal,” said Dr. Philipp Dahm, a professor of urology at the University of Minnesota who was not involved in the guidelines.
The A.C.S. said it was updating its guidance based on new evidence and changes in how doctors monitor and treat prostate cancers.
Thank you for your patience while we verify access. If you are in Reader mode please exit and log into your Times account, or subscribe for all of The Times.
Thank you for your patience while we verify access.
Already a subscriber? Log in.
Want all of The Times? Subscribe.
Advertisement
Source: The New York Times · Nina Agrawal
At a glance
- Topic
- Health
- Country
- 🇺🇸 US
- Publisher language
- EN
- Added to Allnira